Library

Displaying 1 - 25 of 2,412

Developing Targeted Therapy for Genito-Urinary Malignancies

Developing Targeted Therapy for Genito-Urinary Malignancies

By: Amanda Nizam MD

Natural Disasters: Infamy vs. Nature – What Lessons Can We Learn

Natural Disasters: Infamy vs. Nature – What Lessons Can We Learn

By: Antonia Coello Novello, MD, MPH, DR.PH

Natural Disasters: Infamy vs. Nature – What Lessons Can We Learn

Natural Disasters: Infamy vs. Nature – What Lessons Can We Learn

By: Antonia Coello Novello, MD, MPH, DR.PH

Current and Future Directions of Immunotherapy for Breast Cancer

Current and Future Directions of Immunotherapy for Breast Cancer

By: Avan Armaghani, MD, FACP

Physician Leadership and the Urgency of the Moment in Medicine

Physician Leadership and the Urgency of the Moment in Medicine

By: Barbara L. McAneny, MD

Advances in Surgical Treatments for the Breast Cancer Patient

Advances in Surgical Treatments for the Breast Cancer Patient

By: Bolivar Arboleda-Osorio, MD, FACS

Targeted Therapy in Sarcomas Beyond GIST

Targeted Therapy in Sarcomas Beyond GIST

By: Gina D’Amato, MD

Case Study

By: Gubens, Matthew

Immunotherapy in Kidney and Bladder Carcinomas

Immunotherapy in Kidney and Bladder Carcinomas

By: Jorge A. Garcia, MD, FACP

CAR-T Cell as Strategy for the Management of Hematologic Malignancies

CAR-T Cell as Strategy for the Management of Hematologic Malignancies

By: Krishna Komanduri, MD

Optimal Treatment for Early Stage HER2 Positive Breast Cancer: Tailoring Treatment to Response

Optimal Treatment for Early Stage HER2 Positive Breast Cancer: Tailoring Treatment to Response

By: Luis Baez Vallecillo, MD

Addressing Social Determinants of Health (SDOH)

Addressing Social Determinants of Health (SDOH)

By: Luis E. Raez, MD, FACP

Master Lecture on Triple Negative Breast Cancer

Master Lecture on Triple Negative Breast Cancer

By: Mark Pegram, MD

Masters Lecture on Best Neoadjuvant Approaches for Rectal Cancer

Masters Lecture on Best Neoadjuvant Approaches for Rectal Cancer

By: Mike Cusnir, MD

Targeted Therapy for Ovarian and Uterine Tumors

Targeted Therapy for Ovarian and Uterine Tumors

By: Nathalie D. McKenzie, MD, MSPH, DipABLM

Sequencing Endocrine Therapy and Targeted Agents for the Treatment of Metastatic HR+/HER2- Breast Cancer

Sequencing Endocrine Therapy and Targeted Agents for the Treatment of Metastatic HR+/HER2- Breast Cancer

By: Noridza Rodriguez-Rivera, MD

HER2 Targeted Updates in Breast Cancer

HER2 Targeted Updates in Breast Cancer

By: Paolo Tarantino, MD

Master Lecture on HER-2 in Breast Cancer

Master Lecture on HER-2 in Breast Cancer

By: Ragisha Gopalakrishnan, MD

Master Lecture on Endocrine Therapy in Early/Advanced Breast Cancer

Master Lecture on Endocrine Therapy in Early/Advanced Breast Cancer

By: Ricardo H. Alvarez, MD, MsC

Case Study Molecular Testing

Case Study Molecular Testing

By: Riess, Johnathan MD

Changing Delivery of Chemotherapy for Breast Cancer: The Era of Antibody Drug Conjugates

Changing Delivery of Chemotherapy for Breast Cancer: The Era of Antibody Drug Conjugates

By: Wassim Mchayleh, MD, FACP, MBA

Dysphasia in ALS

Dysphasia in ALS

By: Brianna Marchegiani, MS, CCC-SLP

Diagnosing ALS | Understanding ALS

Diagnosing ALS | Understanding ALS

By: Gustavo Alameda, MD, FAAN

Radiating Salivary Glands in Patients with ALS for Sialorrhea

Radiating Salivary Glands in Patients with ALS for Sialorrhea

By: Lav Goyal, MD, MBA

Caring for ALS: What I Wish I knew

Caring for ALS: What I Wish I knew

By: Melissa Alice Jones, PA